Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
AppYea, Investor Presentation November 2022 (OTCQB: APYP)
https://www.reddit.com/r/OTCstockradar/comments/z8zomd/appyea_investor_presentation_november_2022_part_1/
https://www.reddit.com/r/OTCstockradar/comments/z8zoz5/appyea_investor_presentation_november_2022_part_2/
Amazon, Ebay, Google Store Coming Soon!!
Nice PR. This should wake up some investors.
SleepX has Started Marketing its Flagship Product, DreamIT - an AI-Based Wristband to Treat the Snoring Problem Through Biofeedback
https://finance.yahoo.com/news/sleepx-started-marketing-flagship-product-175900028.html
DreamIT's marketing strategy, in addition to online marketing, includes entering Amazon and working with distributors. The company is in discussions with a large Telecom company from Western Europe, a pharmacy chain store and leading mattress manufacturers.
https://www.accesswire.com/729314/SleepX-has-Started-Marketing-its-Flagship-Product-DreamIT--an-AI-Based-Wristband-to-Treat-the-Snoring-Problem-Through-Biofeedback
I wonder why no activity. People may be waiting and watching now, anticipating a move.
I don't know!
That has been on the site for months. Do we have any idea if they’re shipping? Last financial paper indicated they weren’t in production.
DreamIT are now available for Android users.
Order now and get 33% OFF
https://sleepxapp.com/product/sleepx-wristband/
NOW AVAILABLE FOR PURCHASE
https://sleepxapp.com/product/sleepx-wristband/
New US national phase Patent Application No. 17/920,826 For "Systems and Methods for Snoring Detection and Prevention" was filed in the United States Patent and Trademark Office (USPTO)
$APYP
A total of 7 transactions today. Did you see the total amount of shares to be diluted in that document? It was over 100 million.
No~90.,day..market..filing.+.poss'..chips .unavail'.+.if .said./Nov.'pps loss,, leaves us as no update and consider this as .,
1 Opinion but an interesting one
What about the FDA approval before market? There's that process that has a 90 day lead time. No evidence it has been submitted yet.
I’ll try to take it down to .04 with a purchase of 3750 shares.
Yes, it can decelerate fast as well with an accepted transaction at the bid.
Strange accelerating price increases on small lot sizes to get to current high of day price.. lots of games going on here imo directed by the company.
Yeah - paid advertisement a couple weeks back.
https://www.proactiveinvestors.co.uk/companies/news/997701/appyea-alert-to-huge-opportunities-for-its-products-to-stop-snoring-and-sleep-apnea-997701.html?rel=scroll
Watch the video with Appyeah exec Asaf Porat, or read the article
$APYP
Plenty of worries but I appreciate your optimism. Can you link to that statement? The most recent prospectus said production, if ever, is a ways off - IIR.
Glad I bought a bunch yesterday, no worries here. According to Appyeah exec. first batch of product with be on the market before EOY, with 2 new products in "development pipeline" for 2023.
$APYP
How could I not scoop a few at these prices? Matter of time 'til we get updates on production and I'm fine with this being a long term hold with the demand of sleep apnea products (that work) increasing.
Tic toc
Yeah, but with current volumes it's going to take a year to dilute 100 million shares.
Is.,.MM..,incr.''Credibliity..VS..,Nov, Oct..infm..that we read in months earlier that drove pps higher and higher
Where was this benefit in pricing a no revenue OTC higher without what traders were reading
Who put it up to be read
Anyone have any ideas ..to put up
on this being un-answered or somen type of scenario that might appear as a missing in action scene when Nov , Oct came and went and price dropped actually within this period of expected website to take orders and hardware.. hardware coming Nov .. being something to note and read
_
But,,
with first out exit door finding it early to be predictable situ
vs earlier in year scenario on .. watching prices during some previous waits of prolonged silence from.. when ,,
infm was expected and not much given.
Was there infm this CEO has had experience in stock Market before
_
Point made
If becoming a new long watching silence but buying lower
And hard to be a previous long and making it hard to protect profit
Vs
watching the CEO infm to.. come.. around again
but when ..
to be a new investor if .. becoming long at best price is an opp'
I think you’re right about the manipulation, been following that for a while - buying all the way down. I’m just holding and hoping for the best. Who knows, maybe things will work out.
You win some you lose some. Dilution even in relatively reasonable amount killed the balance here. Disappointing indeed
I thought getting in at the low .04 range was a good idea. Not so. This stock is one big disappointment. We're married now. If you try to sell they take very small lots and move the share price down significantly.
I was mistaken here. I thought this company was credible.
Barry..apparent ..has..done.,this..disappear..act...,before
What prices are the financers going to getting those shares at? I didn't see that mentioned.
This Dilution keeps the play alive. They did a r/s and never delivered a real pop and they are diluting again. I am hold for now. Folk need to do their own assessment
I'm thinking it's best to not get any deeper into this overall market. There's too many surprises.
Think this survives or sell?
Stockwits -
APYP form 424B3:
https://newsfilter.io/a/56577c7e439428d18a931c2d335a46e9
Has anybody determined why the share price suddenly dropped over the past week?
I'd like to think the low float will make this move higher on little volume but I think ultimately it's out of our control. There's very little oversight by the regulators these days. It's a rogue market. Haven't made any real money in well over a year. Winter 2020/2021 was the blowout OTC season. I've never seen so many ripe trades to play in the 20 years I've been playing pennies.
Correct - I’ve seen this fluctuate 20% both ways on as few as 9 shares.
That raise in price to .058 was on 200 shares so yes it's manipulated and I doubt it's retail doing it. I don't know what caused the big drop to .041 but knowing the gap from late June it didn't surprise me. I also wouldn't be surprised if it still fills since it got close. The crooks are in charge.
Tell me if I’m wrong. All this can be manipulated. The current price is just the last purchase price. I could raise the price of the stock by purchasing over ask. The bid is what’s ultimately important.
Was it the recent quarterly that was just released? Haven’t read it yet.
Aren't they required to tell us about any material event? I'm hoping it drops more to fill that gap from late June.
this recent price collapse is pretty bad. Some issue behind the scene cause this sell-off
Because it broke down on big volume. I was wondering why it recovered to .049 when the gap just below .04 hasn't been filled. On the daily a couple-three months back..
Not on the breakout board.
Doesn't ihub have boards like that?
Can you share what activity monitors?
I'm surprised there's not more comments today. This stock has to be on some activity monitors now.
Any ideas on the uptick in volume? Buyback? More exposure?
Followers
|
513
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
52607
|
Created
|
10/22/14
|
Type
|
Free
|
Moderators |
Working today for tomorrow's future.
The Diagnostic Center Inc, is a newly formed marketing and service subsidiary of AppYea, Inc. (OTC:APYP) that empowers physician offices, clinics, hospitals, long term care facilities, healthcare groups, employers, governmental units and correctional institutions in getting comprehensive diagnostic testing results quicker. Our goal is to work with multiple diagnostic testing facilities throughout the United States and at the same time using numerous collectors to handle the samples personally therefore expediting the process.
We provide fast and accurate results. With screening results within 24 hours and full confirmation of 78 tests.
https://www.thediagnosticcenters.com/investors/
Boca Raton, FL, and Rehovot, Israel (OTC Pink: APYP) AppYea, Inc. ("AppYea" or the "Company") begun the process to acquire 100% of the outstanding shares of SleepX Ltd., a company formed under the laws of Israel ("SleepX") and Nexense Technologies USA Inc., a Delaware corporation.
Todd Violette, CEO of AppYea stated, "I have been very impressed with the SleepX management team in Israel and SleepXs products and technology. SleepX holds a portfolio of patents and products designed to prevent snoring and sleep apnea, which I believe present a unique opportunity for AppYea."
AppYea management's review of information from Research and Markets September 18, 2020 industry report, indicates the global sleep apnea device market is forecast to increase to US$9.29 billion in 2024, growing at a compounded annual growth rate of 7.94% between 2020-2024. The same report found that the fastest-growing regional market wasNorth America, with the highest incidence of obstructive sleep apnea cases, provided that Europealso represents a large available market.
"SleepX has developed a unique technology for monitoring sleep apnea. The Technology and IP are protected via international patents - sleep apnea detection and sleep phases analysis through sound wave analysis, developed in the Biomedical Department of Ben Gurion University in Beer Sheva, Israel.Based on this technology, one of the leading products SleepX offers is a unique night bracelet for the treatment of snoring using artificial Intelligence", said Bary Molchadsky, CEO of SleepX.
News LINK: https://www.otcmarkets.com/stock/APYP/news/APYP-begin-process-for-Acquisition-of-SleepX-Ltd?id=287757
Boca Raton, FL (OTC Ticker: APYP) Appyea, Inc, on January 28, 2021, announced the entry into a non-binding Letter of Intent (LOI) for the acquisition of SleepX Ltd. from Israel.
https://www.otcmarkets.com/stock/APYP/news/APYP-Update?id=290348
Patent information
https://www.sleepxclear.com/unique-technology
*******************************************************************************************************************************************************************************************************************************************************************
AppYea Holding Inc.
Cannabis Blockchain
One of our subsidiaries, will be going into the Cannabis Blockchain Business. Last year, while I was researching the cannabis industry, I identified some key business models unique to the cannabis industry that are incredibly different from those currently being promoted in the Cannabis Capital Markets. The number one principle that drives the success in the cannabis industry for long term valuation and growth is the principle to acquire the "Customer First." Therefore, building a Cannabis Blockchain for the customers and expanding delivery services that deliver cannabis to people in their homes will be the end target market. I have approved the Subsidiary of AppYea Holding Inc., and the newly formed Canadian Subsidiary will transition, focusing the business development during 2021 on building a Cannabis Blockchain Company.
I view this opportunity based upon the belief that by 2022, California's cannabis market is projected to jump to $5 billion boosted significantly by California's recreational cannabis market. The California cannabis industry's total economic impact could be nearly $10 billion.
The Environmental benefit results from creating a decentralized, encrypted database validating SOP processes as they occur during Cannabis Cultivation. The record's benefit will track the amount of pesticide used, water consumed, and soil degradation.
The Person partaking in the use of the product benefits from a cleaner and better product to enjoy. In the future, we envision the consumer being able to scan the QR code with their phone and use the Blockchain to see the record of the nutrients solution recipe or the amount of pesticide used during the cultivation and packaging process. The end customer will have a history of the Cannabis plant through all stages of the plant's life cycle to verify the final product's product outcome and authenticity.
The Government could begin using the system to be more efficient with tax collections and implementing more effective regulatory policies. We can expect that governments will finally acceptblockchainbenefits and improve critical applications improving tracking financial transactions and ensuring people's identity in the seed to the sale process.
The Cannabis Blockchain cansignificantlyimprove supply chainsby enabling faster and more cost-efficient product deliveries, enhancing product traceability,and enhancingcoordination between customers, drivers, and central locations.
I feel these targeted areas with a combination of proprietary plans will allow the Company to build out a revenue model and use the base assets being developed to potentially generate revenue within the next year. I recently traveled to the Province of Saskatchewan to view a location and meet with a local representative that owns the property for a site that could access power, internet, and host multiple servers. The vision would include developing Agricultural Data and becoming an Ag Tech Datacenter using blockchain technology.
*******************************************************************************************************************************************************************************************************************************************************************
Mr. Todd Violette serves as NEW Chairman of the Board, Chief Executive Officer of the Company. Mr. Violette brings a wealth of experience to AppYea, having spent more than 24 years evaluating and participating investment opportunities across the capital structure of North American companies with a focus on OTC companies. Mr. Violette has worked in a management capacity as a chief executive officer, affecting corporate actions and implementing policies in order to maximize shareholder value. AppYea has previously announced its participation and desire to be in the CBD and Hemp business Mr. Violette disclosed to the Board a potential conflict of interest regarding his outside participation in a project working with a team of experts building 55,000 sq. feet private hemp exaction facility in in Western Kentucky. Any opportunity resulting from this operation will first be brought to AppYea. Mr. Violette graduated of the University of Maryland College Park in 1992.
*******************************************************************************************************************************************************************************************************************************************************************
Contact Information
AppYea Inc.
1-800-674-3561 or Email info@appyea.com
1-800-674-3561 Please Phone or Text Email: info@appyea.com
Twitter Link: https://twitter.com/AppyeaInc/status/1346914866183892994
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |